|
RIN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.383100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.34900000012561E-07 |
| Normal-vs-Stage2 |
5.232600E-01 |
| Normal-vs-Stage3 |
8.210000E-01 |
| Normal-vs-Stage4 |
8.815400E-01 |
| Stage1-vs-Stage2 |
2.247800E-02 |
| Stage1-vs-Stage3 |
3.571600E-04 |
| Stage1-vs-Stage4 |
3.815900E-04 |
| Stage2-vs-Stage3 |
6.901800E-01 |
| Stage2-vs-Stage4 |
5.090400E-01 |
| Stage3-vs-Stage4 |
7.651400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.369500E-04 |
| Normal-vs-AfricanAmerican |
9.303000E-01 |
| Normal-vs-Asian |
7.035400E-01 |
| Caucasian-vs-AfricanAmerican |
6.801600E-02 |
| Caucasian-vs-Asian |
7.835000E-01 |
| AfricanAmerican-vs-Asian |
6.272600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.876300E-03 |
| Normal-vs-Female |
8.296500E-03 |
| Male-vs-Female |
8.903600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.912200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.581100E-04 |
| Normal-vs-Age(61-80Yrs) |
2.899500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.945200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.840400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.681800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.262400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.113200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.041800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.946000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.132130E-02 |
| Normal-vs-Grade 2 |
1.75810000002663E-06 |
| Normal-vs-Grade 3 |
2.117400E-01 |
| Normal-vs-Grade 4 |
1.307440E-01 |
| Grade 1-vs-Grade 2 |
5.331000E-01 |
| Grade 1-vs-Grade 3 |
5.364000E-02 |
| Grade 1-vs-Grade 4 |
2.579500E-03 |
| Grade 2-vs-Grade 3 |
1.022390E-03 |
| Grade 2-vs-Grade 4 |
1.5213600000008E-05 |
| Grade 3-vs-Grade 4 |
2.211700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.20109999910557E-08 |
| Normal-vs-ccB subtype |
8.584500E-02 |
| ccA subtype-vs-ccB subtype |
2.151800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.323500E-03 |
| Normal-vs-N1 |
8.768400E-01 |
| N0-vs-N1 |
2.496400E-01 |
|
|
